Submitted by Anonymous (not verified) on 7 May 2026 - 9:54
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised